BAKER BROS. ADVISORS LP

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 1263508 NEW YORK, NY

Position in PRAX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$564,862,863

+$232,841,790 QoQ

Shares Held

1,753,198

+55.6% QoQ

Ownership

6.29%

of shares outstanding

% of Portfolio

3.26%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BAKER BROS. ADVISORS LP holds $16,600,149,582 across 76 Biotechnology names. PRAX ranks #11 (3.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	30,744,412	$2,893,664,057
2	ONC	BeOne Medicines Ltd.	8,799,053	$2,613,054,769
3	INSM	INSMED Inc	7,421,111	$1,213,500,070
4	MDGL	Madrigal Pharmaceuticals, Inc.	2,141,701	$1,121,116,222
5	ACAD	Acadia Pharmaceuticals Inc	42,896,690	$954,880,319
6	RVMD	Revolution Medicines, Inc.	9,555,357	$929,258,468
7	CELC	Celcuity Inc.	7,915,792	$903,508,498
8	KOD	Kodiak Sciences Inc.	19,919,186	$759,319,370

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$564,862,863	1,753,198	+55.6%	Shares	Sole	2026-05-15
2025-12-31	$332,021,073	1,126,488	+63.4%	Shares	Sole	2026-02-17
2025-09-30	$36,542,864	689,488	0.0%	Shares	Sole	2025-11-14
2025-06-30	$28,992,970	689,488	+108.0%	Shares	Sole	2025-08-14
2025-03-31	$12,555,154	331,533	0.0%	Shares	Sole	2025-05-15
2024-12-31	$25,514,779	331,533	+2.6%	Shares	Sole	2025-02-14
2024-09-30	$18,591,461	323,105	+145.6%	Shares	Sole	2024-11-14
2024-06-30	$5,440,204	131,533	0.0%	Shares	Sole	2024-08-14
2024-03-31	$8,026,143	131,533	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.